Site US10029 — Beverly Hills, California

Site US10029 is a clinical research site located in Beverly Hills, California, United States 90211.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Site US10029 has participated in 1 clinical trials.

Therapeutic areas: Non-small Cell Lung Cancer (NSCLC).

Sponsors: Astellas Pharma Global Development, Inc..

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site US10029?

Site US10029 has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site US10029 conducted?

Site US10029 has 1 clinical trials on record. Their work covers Non-small Cell Lung Cancer (NSCLC).

Is Site US10029 accredited by Crixeo Health?

Site US10029 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site US10029?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.